Comparison of postoperative analgesia of Inter-Transverse Process versus paravertebral catheter after Video-Assisted Thoracoscopic Surgery: a randomized comparative study.

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

PACTR

Registry ID

PACTR202510886861731

Enrollment

Registered

2025-10-29

Start date

2025-06-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

inter transverse process catheter placement and continous infusion of bupivacaine

thorathic paravertebral catheter placement and continous infusion of bupivacaine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.American Society of Anesthesiologists physical status grade I and grade II. 2.Age between 20 and 60 years. 3.Both sexes.

Exclusion criteria

Exclusion criteria: 1.Patient refusal. 2.Hematological diseases, bleeding or coagulation abnormality. 3.Psychiatric diseases. 4.Local skin infection at the site of the block. 5.Known intolerance to the study drugs. 6.Body Mass Index > 40 Kg/m2. 7.history of thoracic surgery 8.severe cardiovascular diseases

Design outcomes

Primary

Measure	Time frame
Total dose of morphine consumption in the first 48 hours after surgery; Total dose of morphine consumption in the first 48 hours after surgery	—

Secondary

Measure	Time frame
-Total intraoperative fentanyl consumption (µg/kg) starting from induction of anaesthesia till the end of surgery. -Postoperative pain score at rest and at movement will be assessed by VAS score at30 min, 2, 6,12,24,48 hour postoperative -Level of sensory blockade. -Time of first request of analgesia (min). -Intraoperative and postoperative hemodynamic changes (invasive mean blood pressure and heart rate). -Adverse effects such as postoperative nausea and vomiting, a fall in blood pressure of more than 20% of the baseline, hematoma and other complications.;-Total intraoperative fentanyl consumption (µg/kg) starting from induction of anaesthesia till the end of surgery. -Postoperative pain score at rest and at movement will be assessed by VAS score at30 min, 2, 6,12,24,48 hour postoperative -Level of sensory blockade. -Time of first request of analgesia (min). -Intraoperative and postoperative hemodynamic changes (invasive mean blood pressure and heart rate). -Adverse effects such as postoperative nausea and vomiting, a fall in blood pressure of more than 20% of the baseline, hematoma and other complications.	—

Measure

Time frame

-Total intraoperative fentanyl consumption (µg/kg) starting from induction of anaesthesia till the end of surgery. -Postoperative pain score at rest and at movement will be assessed by VAS score at30 min, 2, 6,12,24,48 hour postoperative -Level of sensory blockade. -Time of first request of analgesia (min). -Intraoperative and postoperative hemodynamic changes (invasive mean blood pressure and heart rate). -Adverse effects such as postoperative nausea and vomiting, a fall in blood pressure of more than 20% of the baseline, hematoma and other complications.;-Total intraoperative fentanyl consumption (µg/kg) starting from induction of anaesthesia till the end of surgery. -Postoperative pain score at rest and at movement will be assessed by VAS score at30 min, 2, 6,12,24,48 hour postoperative -Level of sensory blockade. -Time of first request of analgesia (min). -Intraoperative and postoperative hemodynamic changes (invasive mean blood pressure and heart rate). -Adverse effects such as postoperative nausea and vomiting, a fall in blood pressure of more than 20% of the baseline, hematoma and other complications.

—

Countries

Egypt

Contacts

Public Contactibrahim abdelbasir

proffessor of anesthesia

ibraheem2005@mans.edu.eg201553032105

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026